Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).
Sugawara M, Fukuda M, Sakuma I, Wakasa Y, Funayama H, Kondo A, Itabashi N, Maruyama Y, Kamiyama T, Utsunomiya Y, Yamauchi A, Yoshii H, Yamada H, Mochizuki K; J-SELECT study investigators. Sugawara M, et al. Among authors: kondo a. Diabetes Ther. 2023 Sep;14(9):1517-1535. doi: 10.1007/s13300-023-01438-w. Epub 2023 Jul 6. Diabetes Ther. 2023. PMID: 37410308 Free PMC article.
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study).
Fukuda M, Sakuma I, Wakasa Y, Funayama H, Kondo A, Itabashi N, Maruyama Y, Kamiyama T, Utsunomiya Y, Yamauchi A, Yoshii H, Yamada H, Mochizuki K, Sugawara M; J-SELECT study investigators. Fukuda M, et al. Among authors: kondo a. Diabetes Ther. 2024 Jun;15(6):1403-1416. doi: 10.1007/s13300-024-01575-w. Epub 2024 Apr 24. Diabetes Ther. 2024. PMID: 38653904 Free PMC article.
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes.
Hara T, Uemoto R, Sekine A, Mitsui Y, Masuda S, Kurahashi K, Yoshida S, Otoda T, Yuasa T, Kuroda A, Ikeda Y, Endo I, Honda S, Yoshimoto K, Kondo A, Tamaki T, Matsumoto T, Matsuhisa M, Abe M, Aihara KI. Hara T, et al. Among authors: kondo a. J Diabetes Investig. 2021 Dec;12(12):2172-2182. doi: 10.1111/jdi.13602. Epub 2021 Jun 23. J Diabetes Investig. 2021. PMID: 34043882 Free PMC article.
Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.
Hara T, Watanabe T, Yamagami H, Miyataka K, Yasui S, Asai T, Kaneko Y, Mitsui Y, Masuda S, Kurahashi K, Otoda T, Yuasa T, Kuroda A, Endo I, Honda S, Kondo A, Matsuhisa M, Aihara KI. Hara T, et al. Among authors: kondo a. Biomedicines. 2024 Aug 7;12(8):1789. doi: 10.3390/biomedicines12081789. Biomedicines. 2024. PMID: 39200252 Free PMC article.
Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.
Hara T, Uemoto R, Sekine A, Mitsui Y, Masuda S, Yamagami H, Kurahashi K, Yoshida S, Otoda T, Yuasa T, Kuroda A, Ikeda Y, Endo I, Honda S, Yoshimoto K, Kondo A, Tamaki T, Matsumoto T, Matsuhisa M, Abe M, Aihara KI. Hara T, et al. Among authors: kondo a. J Atheroscler Thromb. 2023 Aug 1;30(8):871-883. doi: 10.5551/jat.63752. Epub 2022 Oct 14. J Atheroscler Thromb. 2023. PMID: 36244745 Free PMC article.
Designing strong inducible synthetic promoters in yeasts.
Tominaga M, Shima Y, Nozaki K, Ito Y, Someda M, Shoya Y, Hashii N, Obata C, Matsumoto-Kitano M, Suematsu K, Matsukawa T, Hosoya K, Hashiba N, Kondo A, Ishii J. Tominaga M, et al. Among authors: kondo a. Nat Commun. 2024 Dec 19;15(1):10653. doi: 10.1038/s41467-024-54865-z. Nat Commun. 2024. PMID: 39702268 Free PMC article.
2,177 results